Companies
Li

Lila Sciences

Autonomous AI science factories for drug discovery

Founded2025
HQCambridge, MA
StagePlatform
Total Funding$550M
lila.ai
SharePostShare

Overview

Lila Sciences is building 'scientific superintelligence' through autonomous AI-powered research labs called AI Science Factories. Incubated by Flagship Pioneering and unveiled in March 2025, the company uses AI and robotics to autonomously conduct scientific experiments across life sciences. Lila aims to generate genetic medicines and discover new antibodies at unprecedented scale, with NVIDIA NVentures backing its vision of fully autonomous drug discovery.

Focus areas

Platform, Foundation Models, Target Discovery


Funding

$550M

Total raised

Series A Extension2025-10

$115M

Led by NVIDIA NVentures

Seed
$200M2023
Series A
$235M2025-09
Series A ExtensionNVIDIA NVentures
$115M2025-10
Notable investors

Flagship Pioneering · NVIDIA NVentures · General Catalyst


Technology

AI Science Factories — fully autonomous wet-lab + AI research platforms that design, execute, and analyze scientific experiments without human intervention. The system combines robotic lab automation with proprietary AI models to explore vast biological hypothesis spaces at machine speed.

Platforms & Tools
AI Science FactoriesAutonomous experimentation platform

Leadership

Geoffrey von Maltzahn

CEO

Flagship Pioneering platform leader, MIT-trained biomedical engineer


Similar companies

Get updates on Lila Sciences

We'll notify you when we publish updates about Lila Sciences.